186 related articles for article (PubMed ID: 23629443)
21. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
23. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in head and neck mucosal malignant melanoma.
Çomoğlu Ş; Polat B; Çelik M; Şahin B; Enver N; Keleş MN; Sarı ŞÖ
Auris Nasus Larynx; 2018 Feb; 45(1):135-142. PubMed ID: 28385366
[TBL] [Abstract][Full Text] [Related]
25. Phospho-histone-H3 immunostaining for pulmonary carcinoids: impact on clinical appraisal, interobserver correlation, and diagnostic processing efficiency.
Laflamme P; Mansoori BK; Sazanova O; Orain M; Couture C; Simard S; Trahan S; Manem V; Joubert P
Hum Pathol; 2020 Dec; 106():74-81. PubMed ID: 33007357
[TBL] [Abstract][Full Text] [Related]
26. Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast.
Ginter PS; Shin SJ; Liu Y; Chen Z; D'Alfonso TM
Hum Pathol; 2016 Mar; 49():90-8. PubMed ID: 26826415
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.
Ikenberg K; Pfaltz M; Rakozy C; Kempf W
J Cutan Pathol; 2012 Mar; 39(3):324-30. PubMed ID: 22335591
[TBL] [Abstract][Full Text] [Related]
28. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
Bedin V; Adam RL; de Sá BC; Landman G; Metze K
BMC Cancer; 2010 Jun; 10():260. PubMed ID: 20525386
[TBL] [Abstract][Full Text] [Related]
29. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
[TBL] [Abstract][Full Text] [Related]
30. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
31. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.
Storr SJ; Safuan S; Mitra A; Elliott F; Walker C; Vasko MJ; Ho B; Cook M; Mohammed RA; Patel PM; Ellis IO; Newton-Bishop JA; Martin SG
Mod Pathol; 2012 Apr; 25(4):493-504. PubMed ID: 22080065
[TBL] [Abstract][Full Text] [Related]
32. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.
Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA
Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821
[TBL] [Abstract][Full Text] [Related]
33. Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients.
Rosenbaum BE; Schafer CN; Han SW; Osman I; Zhong H; Brinster N
Mod Pathol; 2017 Oct; 30(10):1402-1410. PubMed ID: 28731044
[TBL] [Abstract][Full Text] [Related]
34. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.
Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K
Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855
[TBL] [Abstract][Full Text] [Related]
35. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma.
Piñero-Madrona A; Ruiz-Merino G; Cerezuela Fuentes P; Martínez-Barba E; Rodríguez-López JN; Cabezas-Herrera J
Clin Transl Oncol; 2019 Oct; 21(10):1348-1356. PubMed ID: 30783917
[TBL] [Abstract][Full Text] [Related]
36. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
37. Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain.
Thareja S; Zager JS; Sadhwani D; Thareja S; Chen R; Marzban S; Jukic DM; Glass LF; Messina J
Am J Dermatopathol; 2014 Jan; 36(1):64-7. PubMed ID: 24451214
[TBL] [Abstract][Full Text] [Related]
38. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.
Alkhasawneh A; Reith JD; Toro TZ; Ayed AO; Lu X; George TJ; Duckworth LV
Am J Clin Pathol; 2015 Mar; 143(3):385-92. PubMed ID: 25696796
[TBL] [Abstract][Full Text] [Related]
39. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
40. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma.
Henderson SA; Tetzlaff MT; Pattanaprichakul P; Fox P; Torres-Cabala CA; Bassett RL; Prieto VG; Richards HW; Curry JL
J Cutan Pathol; 2014 Nov; 41(11):846-52. PubMed ID: 25263506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]